Reporte zur Charge U726BAB

Symptomtext

she gave MENACTRA and BEXSERO in the same syringe to a patient with no reported adverse event; Initial information received on 08-Jul-2022 regarding an unsolicited valid non-serious case received from a physician. This case involves a 56 years old female patient and reported stated that she gave BEXSERO and MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] in the same syringe to a patient with no reported adverse event. The patient's past medical history, medical treatment(s),concomitant medication, vaccination(s) and family history were not provided. On 06-Jul-2022, the patient received 0.5 ml 1X (once) dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (Formulation was unknown, lot U726BAB and expiry date: 22-Apr-2023) via intramuscular route in right deltoid for Immunization On an unknown date, the patient received an unknown dose of suspect BEXSERO not produced by Sanofi Pasteur (Formulation, lot number and expiry date was unknown) via unknown route in unknown administration site for Prophylactic vaccination. On 06-Jul-2022 the patient developed a non-serious event of she gave menactra and bexsero in the same syringe to a patient with no reported adverse event (multiple use of single-use product) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and (unknown latency) following the administration of BEXSERO. Action taken : not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.